FDA Approved: TAUVID — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for Tauvid (flortaucipir F-18) enabling its use for PET imaging of tau neurofibrillary tangles in adult patients with co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Tauopathies

Drugs mentioned

• Tauvid (Flortaucipir (18F))

Snippet

SUPPL AP for TAUVID (FLORTAUCIPIR F-18)